Futura Medical plc announced that Ken James, who was appointed to the company as a Non-Executive Director in March 2016, is joining the company's executive team as an Executive Director and Head of R&D with immediate effect. Mr. James is the former head of consumer healthcare R&D at GlaxoSmithKline where he brought more than 200 innovative products to market. In the newly created role of Head of R&D at Futura, Mr. James will oversee the development, regulatory and manufacturing strategies for the Company's existing pipeline of products and the evaluation of earlier stage pipeline opportunities. Mr. James's role as Head of R&D will include directing the further development of MED2002, the Company's novel, topical treatment for erectile dysfunction (ED), which delivered positive results from a clinical study announced on 7 September 2016.